Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- befree-2016 importedOn "2016-02-19" NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_assertion wasGeneratedBy ECO_0000203 NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_assertion wasDerivedFrom befree-2016 NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_assertion SIO_000772 23775793 NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_assertion evidence source_evidence_literature NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.
- NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_assertion description "[Human osteosarcoma U2OS cells treated with anti-cancer drugs Doxorubicin (DXR) or Nutlin-3 (Nutlin) led to strikingly different p53 gene binding patterns based on chromatin immunoprecipitation with high-throughput sequencing experiments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1086851.RAc-j1vLPWCvGQYAfUrkga8j22FJWBJYPX7GtDjk46A4s130_provenance.